Summary of Findings
Research Reports
Research Meetings
How to Apply
Research Resources
Line
 
picture
  Joshua Corbin

Joshua Corbin, PhD, Principal Investigator
Molly Huntsman, PhD, Co-Investigator
George Washington University

FRAXA Awards:
  $50,000 in 2010 
  $50,000 in 2009 
Rescue of GABAergic transmission defects in the amygdala in the Fmr1-/- mutant mouse model of Fragile X Syndrome
This team is examining the role of particular class of brain cells (inhibitory interneurons) that dampen excessive activity in the “emotional center of the brain” (the amydala). This inhibition is deficient in Fragile X, and so they are looking for ways to remedy this.

This is particularly interesting to parents of children who are overly anxious and emotional. They are working with Dr. Walter Kaufmann, a clinician at Kennedy Krieger Institute in Maryland.
by Joshua Corbin, 5/2009

The proper functioning of neuronal circuits in the mature brain is dependent on maintenance of the normal balance between excitatory and inhibitory neuronal transmission. In Fragile X Syndrome, there is an overexcitation within neuronal circuits, which manifests as alterations in brain function.

Work in our laboratory is directed toward understanding and correcting deficiencies in inhibitory, GABAergic transmission in Fragile X Syndrome. Toward this goal, we are focusing our studies on amygdala synaptic function and dysfunction in the Fmr1-/- knockout mouse model of Fragile X Syndrome. The amygdala is a highly relevant and little examined brain region in relation to Fragile X Syndrome pathogenesis. It performs a number of distinct functions, most prominently in the integration and processing of information with emotional salience, especially negative emotions such as fear. The amygdala is also involved in the regulation of attention and eye gaze, as well as modulation of anxiety state and social avoidance responses, most of which are abnormal in Fragile X Syndrome. Using a combination of mouse genetic and pharmacological approaches, this project is designed to rescue the abnormalities in inhibitory synaptic dysfunction in the amygdala in the Fmr1-/- knockout mouse.

more FRAXA research reports

 
Join FRAXA Mailing List
 
 




©1997-2010 FRAXA Research Foundation, 45 Pleasant St., Newburyport, MA 01950. Tax ID: 04-3222167. Contact Us
Editor/writers: Katie Clapp, MS, and Michael Tranfaglia, MD. Updated 5/23/10. All rights reserved. Disclaimer Created by Dave Fullam and Icovia